Press Releases :: Cellectar Biosciences, Inc. (CLRB)

Year

Release Type

Jul 1, 2020

Cellectar Appoints Dr. John Friend as Chief Medical Officer

Jun 11, 2020

Cellectar to be Granted EU Patent for Phospholipid Ether (PLE) Analogs as Cancer-Targeting Drug Vehicles

Jun 5, 2020

Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering

Jun 3, 2020

Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering